TARESSA BROUSSARD: Open Payments
NPI 1205323524 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 60 payments from 31 companies in 2025. Trend: 2023 $651 · 2024 $1,582 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $141 |
| Daiichi Sankyo Inc. | 4 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Incyte Corporation | 4 | $76 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| PFIZER INC. | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| PharmaEssentia USA Corporation | 2 | $52 |
| JAZZ PHARMACEUTICALS INC. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $47 |
Products named: RYBREVANT, Enhertu, JEMPERLI, TALVEY, DATROWAY, LIBTAYO, BESREMI, ZIIHERA.
Industry payments across LA — which companies pay providers there.
